• About us
• Contact

Advertisement

Person › Details

Kader Thiam (genOway S.A. (Euronext Growth: ALGEN))

Thiam, Kader (genOway 201809 VP Transgenic Technologies)

 

	Organisation	genOway S.A. (Euronext Growth: ALGEN)
	Group	genOway (Group)
	Product	transgenic animal technology
	Product 2	transgenic mouse

Record changed: 2020-03-28

Advertisement

More documents for Kader Thiam

• [1] genOway S.A.. (1/25/22). "Press Release: genOway Grants the Leading UK Academic Research Funder a Non-exclusive License for CRISPR/Cas9 Technology". Lyon....
• [2] genOway S.A.. (6/4/19). "Press Release: genOway Announces the Consolidation of a Precompetitive Consortium to Develop and Validate Humanized Immune Checkpoint Mouse Models". Lyon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.